Stocktoria

Vivani Medical, Inc. VANI

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2014-12-05

Vivani Medical, Inc. statistics & valuation

Market cap$100.9M
P / B6.4×
Return on capital-84%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
-152.30% 35.70% 29.10% 36.30% 2016201720182019202020212022202320242025
Operating margin (%)
-830.20% -359.20% -509.90% -1004.90% 2016201720182019202020212022202320242025
Return on equity (%)
-297.60% -361.80% -1137.90% -461.70% -763.10% -518.20% -31.30% -123.60% -133.40% -169.20% 2016201720182019202020212022202320242025
Shares outstanding
42.7M 57.6M 9.5M 15.6M 23214 36.8M 50736 51.0M 59.2M 76.4M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-197.40% -196.70% -328.50% -202.40% -333.60% -234.20% -27.20% -56.00% -56.50% -67.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-639.00% -304.00% -434.40% -832.30% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.50 -$0.43 -$0.43 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin36.3%29.1%35.7%-152.3%
Operating margin-1004.9%-509.9%-359.2%-830.2%
Net margin-994.1%-508.6%-358.1%-829.5%
FCF margin-832.3%-434.4%-304.0%-639.0%
Return on assets-67.5%-56.5%-56.0%-27.2%-234.2%-333.6%-202.4%-328.5%-196.7%-197.4%
Return on equity-169.2%-133.4%-123.6%-31.3%-518.2%-763.1%-461.7%-1137.9%-361.8%-297.6%
Current ratio2.713.414.036.971.180.831.881.271.992.70

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.